About Us

The UCLA Division of Infectious Diseases conducts groundbreaking research that improves the lives of patients around the world. With around $140 million in 2024 annual research funding, we serve as both a hub and a launchpad for ambitious scientists who develop new treatments for HIV, investigate prevention methods for immune-mediated for immune-mediated of organ transplantation, take a “bench-to-bedside" approach to designing new immunotherapies and vaccines and much more. Our researchers conduct wide-ranging clinical studies on hospital-acquired infections, fungal and other infections in immunocompromised patients, influenza, sexually transmitted infections in high-risk patients, and co-infections and complications of HIV and hepatitis viruses. 

Scientists within the infectious diseases division at UCLA leverage several centers and clinical trials networks through which they can study the efficacy of behavioral and pharmacological interventions against viral and bacterial pathogens. These resources are also available to physicians and scientists who take part in the division’s state-of-the-art education opportunities. Trainees in our fellowship programs are mentored by world-renowned experts whose research leads to new therapies and informs public policies and treatment guidelines around infectious disease management. 

While the division’s home base is in Los Angeles, its reach extends across the globe. Our prolific global health programs collaborate with partner organizations in Malawi, Botswana, South Africa, Zambia, Peru, Colombia, Argentina, Brazil, Vietnam, Cambodia, Ghana and Thailand. These programs immerse the next generation of physicians and scientists into the management of emerging global pathogens, HIV, viral hepatitis, sexually transmitted infection and issues unique to low-resource communities.